- Home
- ACLX vs AVNT Comparison
ACLX vs AVNT Comparison
Compare ACLX & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- AVNT
- Stock Information
- Founded
- ACLX 2015
- AVNT 1927
- Country
- ACLX United States
- AVNT United States
- Employees
- ACLX 163
- AVNT N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- AVNT Major Chemicals
- Sector
- ACLX Health Care
- AVNT Industrials
- Exchange
- ACLX Nasdaq
- AVNT Nasdaq
- Market Cap
- ACLX 3.5B
- AVNT 3.4B
- IPO Year
- ACLX 2022
- AVNT 1993
- Fundamental
- Price
- ACLX $63.00
- AVNT $33.45
- Analyst Decision
- ACLX Strong Buy
- AVNT Strong Buy
- Analyst Count
- ACLX 14
- AVNT 5
- Target Price
- ACLX $111.42
- AVNT $49.40
- AVG Volume (30 Days)
- ACLX 631.2K
- AVNT 540.6K
- Earning Date
- ACLX 08-07-2025
- AVNT 08-05-2025
- Dividend Yield
- ACLX N/A
- AVNT 3.23%
- EPS Growth
- ACLX N/A
- AVNT N/A
- EPS
- ACLX N/A
- AVNT 1.08
- Revenue
- ACLX $76,809,000.00
- AVNT $3,238,000,000.00
- Revenue This Year
- ACLX N/A
- AVNT $2.98
- Revenue Next Year
- ACLX $112.68
- AVNT $4.17
- P/E Ratio
- ACLX N/A
- AVNT $30.89
- Revenue Growth
- ACLX N/A
- AVNT 3.58
- 52 Week Low
- ACLX $47.86
- AVNT $27.86
- 52 Week High
- ACLX $107.37
- AVNT $54.68
- Technical
- Relative Strength Index (RSI)
- ACLX 47.45
- AVNT 36.47
- Support Level
- ACLX $64.77
- AVNT $34.18
- Resistance Level
- ACLX $66.73
- AVNT $38.28
- Average True Range (ATR)
- ACLX 2.89
- AVNT 0.96
- MACD
- ACLX -0.35
- AVNT -0.40
- Stochastic Oscillator
- ACLX 25.18
- AVNT 3.01
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.